Serum and tissue pharmacokinetics of silibinin after per os and i.v. administration to mice as a HP-β-CD lyophilized product-Reference-Cited by-同舟云学术

Serum and tissue pharmacokinetics of silibinin after per os and i.v. administration to mice as a HP-β-CD lyophilized product

Published:2015-09 Issue:1-2 Volume:493 Page:366-373
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Christodoulou Eirini,Kechagia Irene-Ariadne,Tzimas Stavros,Balafas Evangelos,Kostomitsopoulos Nikolaos,Archontaki Helen,Dokoumetzidis Aristides,Valsami Georgia

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference39 articles.

1. Milk thistle in liver diseases: past, present and future;Abenavoli;Phytother. Res.,2010

2. Cyclodextrins as pharmaceutical solubilizers;Brewster;Adv. Drug Del. Rev.,2007

3. Cyclodextrins in drug delivery: an updated review;Challa;AAPS PharmSciTech,2005

4. Silymarin as a new hepatoprotective agent in experimental cholestasis: new possibilities for an ancient medication;Crocenzi;Curr. Med. Chem.,2006

5. Cyclodextrin-based pharmaceutics: past, present and future;Davis;Nat. Rev. Drug Discovery,2004

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silybin A fromSilybum marianumreprograms lipid metabolism to induce a cell fate-dependent class switch from triglycerides to phospholipids;2024-04-11

2. Enhancing the Bioavailability of Silymarin Phytopharmaceutical by using Piperine and Fulvic Acid and Simultaneously Quantifying Three Biomarkers in Plasma;Current Analytical Chemistry;2023-11

3. Leveraging the use of in vitro and computational methods to support the development of enabling oral drug products: An InPharma commentary;European Journal of Pharmaceutical Sciences;2023-09

4. Nose-to-Brain delivery of donepezil hydrochloride following administration of an HPMC-Me-β-CD-PEG400 nasal film in mice;Journal of Drug Delivery Science and Technology;2023-06

5. Opportunities and challenges of physiologically based pharmacokinetic modeling in drug delivery;Drug Discovery Today;2022-08